Flywire (FLYW) director receives 28,225 restricted stock units as equity grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Katziff Christine reported acquisition or exercise transactions in this Form 4 filing.
Flywire Corp director Christine Katziff received an equity grant of 28,225 shares of Voting Common Stock in the form of restricted stock units. The award was granted at no cash cost to her and represents her entire reported direct holding after this transaction.
The RSUs vest in three equal annual installments following the grant date, as long as she continues providing service to Flywire through each vesting date. The award will fully vest earlier if there is a change in control of the company or upon her death or disability.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Katziff Christine
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Voting Common Stock | 28,225 | $0.00 | -- |
Holdings After Transaction:
Voting Common Stock — 28,225 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What did Flywire (FLYW) director Christine Katziff report in this Form 4?
Christine Katziff reported receiving 28,225 shares of Flywire Voting Common Stock as a restricted stock unit award. The grant increased her direct holdings to 28,225 shares, with no corresponding open-market purchase or sale activity disclosed in this filing.
How do the 28,225 RSUs granted to Flywire (FLYW) director vest over time?
The 28,225 restricted stock units vest in three equal annual installments after the grant date. Each installment requires Christine Katziff to remain in continuous service with Flywire through the applicable vesting date for those units to become fully owned shares.
Are there any acceleration provisions on the Flywire (FLYW) RSU grant to Christine Katziff?
Yes. The RSU award will fully accelerate and vest if there is a change in control of Flywire, or upon Christine Katziff’s earlier death or disability, overriding the normal three-year annual vesting schedule described in the filing.